SGLT2 inhibitors and finerenone in non-diabetic CKD: a step into the (near) future?
Author:
Affiliation:
1. First Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki , Thessaloniki, Greece
Publisher
Oxford University Press (OUP)
Subject
Transplantation,Nephrology
Link
https://academic.oup.com/ckj/advance-article-pdf/doi/10.1093/ckj/sfad272/52760845/sfad272.pdf
Reference19 articles.
1. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases;Jager;Nephrol Dial Transplant,2019
2. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories;Foreman;Lancet,2018
3. Economic evaluation of dialysis therapies;Klarenbach;Nat Rev Nephrol,2014
4. Targeting the progression of chronic kidney disease;Ruiz-Ortega;Nat Rev Nephrol,2020
5. Aggressive blood pressure reduction and renin-angiotensin system blockade in chronic kidney disease: time for re-evaluation?;Sarafidis;Kidney Int,2014
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3